Recommended Topic Related To:

Pfizerpen

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Pfizerpen

PATIENT INFORMATION

Patients should be counseled that antibacterial drugs including Pfizerpen (penicillin g potassium) should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Pfizerpen (penicillin g potassium) is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Pfizerpen (penicillin g potassium) or other antibacterial drugs in the future.

Last reviewed on RxList: 6/27/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.